Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1UP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,967
Award facts
- Contract value 100% obligated
- $22,966.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,966.61 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on December 3, 2025, with completion scheduled for December 4, 2025. This non-set-aside, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat inflammatory conditions, reflecting the breadth of specialty pharmaceutical products the company supplies through its federal contracts.
This delivery order is issued under AmerisourceBergen's SPE2DX indefinite delivery contract with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical commodities globally to support military healthcare programs. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen consistently wins competitively awarded delivery orders across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's significant scale and portfolio position it as a key participant in DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FG1UP?
SPE2DR26FG1UP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FG1UP worth?
The government has obligated $22,967 on SPE2DR26FG1UP.
Is contract SPE2DR26FG1UP an order under another contract?
Yes. SPE2DR26FG1UP is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1UP competed?
The extent of competition for SPE2DR26FG1UP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award